A5065848499- Pharmaceutical Economics and Policy
- Acute Myeloid Leukemia Research
- Pharmacology and Obesity Treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Endometriosis Research and Treatment
- Pharmaceutical Practices and Patient Outcomes
- Intraperitoneal and Appendiceal Malignancies
- Clinical practice guidelines implementation
- Health Systems, Economic Evaluations, Quality of Life
- Meta-analysis and systematic reviews
- Ovarian cancer diagnosis and treatment
Hospital Clínico Universitario de Valencia
2011-2019
Hospital Arnau de Vilanova
2017
The main reason for conducting a clinical trial (CT) is to test the effect of drug or medical procedure improve treatment disease. CTs contribute most when they are rigorously conducted and results published adequately. aim this study assess, using CONSORT statement guidelines, quality reporting completed at tertiary hospital determine which sections articles should be improved. between 2002 2008 were identified by searching MEDLINE Cochrane Library. Forty 127 published. There was marked...
<h3>Background</h3> Azacitidine is the recommended treatment for higher-risk myelodysplastic syndromes (MDS) in patients who are not candidates haematopoietic transplantation. It also used low-risk MDSs where supportive fails. Despite its widespread use, there no pharmacoeconomic data of azacitidine based real-world setting, outside context clinical trials. <h3>Purpose</h3> To evaluate incremental cost-effectiveness ratio versus care with MDS treated a public hospital, from payers'...